phase readout
saveNCT06751524: Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval
AVAILABLEupdated 46m ago
community read0 votes
Sponsor: Agenus Inc.. Phase: . Conditions: Colorectal Cancer (CRC), Pancreatic Cancer, Non-Small Cell Lung Cancer (NSCLC), Hepatocellular Carcinoma (HCC), Melanoma, Sarcoma, Ovarian Cancer, Prostate Cancer
view source ↗
comments(0)
5-min edit window · permanent after that